Q4 met the street's expectations
07/02/25 -"GN’s Q4 results met market expectations. Healthy growth in the Hearing segment was counterbalanced by a weaker performance in Gaming & Consumer and Enterprise. For 2025, management expects ..."
Pages
65
Language
English
Published on
07/02/25
You may also be interested by these reports :
12/11/26
Sonova’s H1 results exceeded expectations. The Hearing Instruments segment drove sales growth, partly offset by weakness in Cochlear Implants. ...
12/11/26
Ottobock delivered a solid 3Q26, in line on sales and slightly ahead on profitability. Core revenues grew by +9.0% to €433.4m (organic +6.4%). B2B ...
11/11/26
The Q3 sales and profitability met expectations; however, a slight guidance downgrade disappointed investors. Healthy growth in all sub-segments was ...
09/11/26
Qiagen’s Q3 results exceeded management’s guidance, with sales primarily driven by Sample Technologies and Genomics/NGS. However, challenges in US ...